ICPT : Summary for Intercept Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
106.04+3.30 (+3.21%)
At close: 4:00 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close102.74
Bid102.00 x 300
Ask127.49 x 1500
Day's Range103.43 - 106.86
52 Week Range89.76 - 177.93
Avg. Volume471,667
Market Cap2.63B
PE Ratio (TTM)-6.83
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire23 hours ago

    Intercept to Present at Upcoming Investor Conference

    NEW YORK, Dec. 09, 2016-- Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, ...

  • 24/7 Wall St.5 days ago

    10 Major Pharma and FDA Catalysts Coming in December

    24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.

  • Intercept Pharmaceuticals Inc (ICPT): Are Hedge Funds Right About This Stock?
    Insider Monkey6 days ago

    Intercept Pharmaceuticals Inc (ICPT): Are Hedge Funds Right About This Stock?

    Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ a complex analysis to determine the best stocks to invest in. A particularly […]